Cannlabs (OTCMKTS:CANL – Get Free Report) and PACS Group (NYSE:PACS – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, valuation, earnings and dividends.
Risk & Volatility
Cannlabs has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, PACS Group has a beta of -0.68, suggesting that its stock price is 168% less volatile than the S&P 500.
Earnings and Valuation
This table compares Cannlabs and PACS Group”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cannlabs | N/A | N/A | N/A | N/A | N/A |
| PACS Group | $4.09 billion | 1.51 | $55.76 million | $1.05 | 37.67 |
PACS Group has higher revenue and earnings than Cannlabs.
Analyst Recommendations
This is a summary of current ratings and price targets for Cannlabs and PACS Group, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cannlabs | 0 | 0 | 0 | 0 | 0.00 |
| PACS Group | 1 | 1 | 5 | 0 | 2.57 |
PACS Group has a consensus price target of $39.40, indicating a potential downside of 0.39%. Given Cannlabs’ higher possible upside, analysts clearly believe Cannlabs is more favorable than PACS Group.
Profitability
This table compares Cannlabs and PACS Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cannlabs | N/A | N/A | N/A |
| PACS Group | 3.29% | 21.39% | 3.09% |
Summary
PACS Group beats Cannlabs on 6 of the 8 factors compared between the two stocks.
About Cannlabs
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
About PACS Group
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Receive News & Ratings for Cannlabs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannlabs and related companies with MarketBeat.com's FREE daily email newsletter.
